Life Sciences Enterprise Storage Market
Life Sciences Enterprise Storage Market Study by Storage-Area Network, Network-Attached Storage, Direct-Attached Storage, Software-Defined Storage, and Hybrid Systems from 2023 to 2033
Analysis of Life Sciences Enterprise Storage Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Life Sciences Enterprise Storage Market Outlook (2023-2033)
The global life sciences enterprise storage market is set to surpass a valuation of US$ 2.6 billion in 2023 and further expand at a CAGR of 5.6% to reach US$ 4.5 billion by the end of 2033.
Revenue generation from life sciences enterprise storage accounted for nearly 6% of overall data analytics market in 2022.
Report Attributes |
Details |
|
Life Sciences Enterprise Storage Market Size (2022A) |
US$ 2,490 Million |
|
Estimated Market Value (2023E) |
US$ 2,637.7 Million |
|
Forecasted Market Value (2033F) |
US$ 4,548.5 Million |
|
Global Market Growth Rate (2023-2033) |
5.6% CAGR |
|
North America Market Share (2023) |
~ 34.3% |
|
North America Market Value (US$ Mn), 2023 |
US$ 903.7 Million |
|
Europe Market Share (%), 2023 |
~26.1% |
|
Europe Market Value (US$ Mn), 2023 |
US$ 689.5 Million |
|
China Market Share (%), 2023 |
~10.5% |
|
China Market Value (US$ Mn), 2023 |
US$ 275.8 Million |
|
Top 3 country Market Share (%) |
~49.1% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Life Sciences Enterprise Storage Market (2018-2022) Vs. Market Forecast Outlook (2023-2033)
As per the research by Fact.MR, from 2018 to 2022, the market value of life sciences enterprise storage market increased at a rate of 4.1% CAGR, with Germany and China commanding high shares in the global market.
Life sciences enterprise storage refers to the storage solutions designed specifically to meet the needs of the life sciences industry. This includes the storage, management, and analysis of large amounts of data generated by modern biomedical research, such as genomics and imaging, as well as patient data from precision medicine.
Life sciences enterprise storage solutions can be used by a variety of organizations in the life sciences industry, including pharmaceutical companies, medical device manufacturers, research institutions, and healthcare organizations. These solutions are critical for the efficient storage, management, and analysis of the massive amounts of data being generated in the life sciences field, and for compliance with regulatory requirements.
Life sciences enterprise storage solutions are typically designed to handle large amounts of data, provide advanced analytics and machine learning capabilities, comply with regulatory requirements, and protect sensitive data. Fact.MR estimates that the growth of the global life sciences enterprise storage market will be 1.7 times by 2033, creating an absolute dollar opportunity of US$ 2 Bn over the forecast period.
- Short Term (2023 Q1 to 2026): The increasing amount of data being generated by the life sciences industry including data from genomics, imaging, and other research areas to aid the market growth.
- Medium Term (2026-2029): The growing stringent regulatory environment for the life science industry would contribute to the market growth.
- Long Term (2029-2033): The growing use of precision medicine leading to an increase in amount of data being collected will improve long-term growth in the market.
What’s Driving Demand for Life Sciences Enterprise Storage?
The Increasing Amount of Data Generated in Life Sciences to Drive the Market Growth
The increasing amount of data generated in the life sciences field is a result of various factors, including advancements in technology and research techniques, as well as an increase in the number of studies being conducted. This data includes genetic sequencing information, clinical trial results, imaging data, and more. These large and complex datasets require efficient storage and management in order to be analyzed and used for research and development.
The increasing use of electronic health records (EHRs) and other digital tools in healthcare also leads to the generation of large amounts of data. Clinical trials and research studies are another source of data in the life sciences. The amount of data generated by these studies has increased as more complex studies are conducted, and more data is collected from participants. As a result, there is a growing demand for enterprise storage solutions that are specifically designed for the unique needs of the life sciences industry.
The Growing Use of Analytics and Machine Learning in Life Sciences to Elevate Market Growth
As more life science companies are turning to advanced analytics and machine learning techniques to gain insights from their data, the need for high-performance storage solutions that can handle large and complex datasets is becoming more pressing. These techniques often involve processing large amounts of data in real-time, which requires storage systems that can handle high throughput and low latency.
Big data analytics and distributed computing in life sciences require the management and storage of massive datasets across numerous locations, necessitating the use of storage systems created for distributed environments. Additionally, machine learning models require to be constantly trained on new data and retrained on updated data, which requires storage systems that can handle the storage and transfer of large amounts of data quickly, efficiently and securely. As a result, the demand for enterprise storages in life sciences is estimated to witness considerable growth in successive years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Concerns Should Life Sciences Enterprise Storage Providers Watch Out for?
Data Security & Privacy Concerns may Pose a Threat to Market Growth
There has been a significant increase in cyber attacks on the life sciences and healthcare sectors, including at the World Health Organization. Pharmaceutical companies are increasingly being targeted for cyberattacks, according to an alert from the FBI. The life sciences industry heavily relies on cloud data storage providers for storing massive data from research and developments and any type of reliance on a third party raises a threat for data breaches.
In the life sciences industry, sensitive data is often collected and stored, including personal health information (PHI) and proprietary research data. This data must be protected from unauthorized access, alteration, and disclosure, as well as from natural disasters and other potential data loss scenarios. Due to these reasons, it is often advised for life sciences companies to restrict vendor access to personal information, especially sensitive category data, which may pose a threat to market growth.
Country wise Insights
How will United States be an Opportunistic Market for Life Sciences Enterprise Storage Market?
The United States is home to a large and diversified life sciences industry, which includes pharmaceutical, biotechnology, and medical device companies. These businesses generate massive data, which necessitates the use of effective storage options.
The U.S government has implemented policies to support the life sciences industry and encourage innovation, including promotion of data sharing and collaboration initiatives. According to Fact. MR's estimate, the US market is anticipated to generate US$ 780.7 million by 2023.
The U.S has a strong infrastructure for the storage and analysis of big data, which includes robust IT infrastructure, large amounts of computational resources, and well-established data management practices. Because of this, it is a desirable nation for life sciences enterprise storage firms. In 2023, US is anticipated to have a value of US$ 780.7 Mn, holding a market share of 29.6% at global level.
What Makes China Growth Epicenter for the Life Sciences Enterprise Storage?
In recent years, China's life sciences sector has expanded quickly owing to increased government support, private company investments, and an increase in the number of biotech and pharmaceutical firms. China has made significant advances in technology, particularly in the areas of genomics, AI and big data. This has led to an increase in the amount of data being generated, creating a need for data storage solutions.
In addition, the Chinese government has been making significant investments in data-driven research and development, particularly in the field of life sciences, which will drive the demand for life science enterprise storage solutions. China is estimated to reach a valuation of US$ 275.8 Mn in 2023 and is expected to grow at a CAGR of 3.7% over forecast period.
Category wise Insights
How On-Cloud Deployment is Likely to Witness an Accelerated Growth?
Cloud-based deployment allows vendors to offer storage solutions that are highly scalable, which is particularly important for life sciences companies that generate large amounts of data and require flexible storage capacity. It eliminates the need for expensive IT infrastructure, such as servers and storage devices, and allows vendors to offer more cost-effective storage solutions.
The trend of cloud-based storage solutions will continue to grow as it provides companies the ability to store, manage, and analyze large amounts of data in a secure, compliant, and efficient manner. On-cloud life sciences enterprise storage is likely to hold a market valuation of US$ 1.7 Bn in 2023 and hold a market share of 66.3%.
How Pharmaceutical End Use Industry to be Focus for Life Science Enterprise Storage Vendors?
Pharmaceutical companies are generating large amounts of data through activities such as drug discovery and development, clinical trials, and post-market surveillance. This data needs to be stored and managed, efficiently, which drives the demand for specialized storage solutions. The data generated from the drug discovery and development process includes large amounts of genomic data from high-throughput sequencing, chemical compounds and assay data that needs to be stored and managed.
In addition, the pharmaceutical industry is increasingly collaborating with other companies and research institutions in the life sciences industry, which is driving the need for storage solutions that allow for easy data sharing and collaboration between different teams and researchers located in different locations. The pharmaceuticals end use industry will have a valuation of around US$ 508 Mn in 2023 and hold a share of 19.3% of the overall market.
Competitive Landscape
Prominent players of life sciences enterprise storage globally are Amazon Web Services, BigMIND Home, Cloudian, DDN, Dell Inc., Fujitsu, Hitachi, HPE, Huawei, IBM, Microsoft Azure, NetApp, Nutanix, Oracle, Pure Storage, Qumulo, Rackspace, Red Hat, Scality, StorCentric, Inc, SUSE, Violin Systems, Western Digital and Zoolz. Life Sciences enterprise storage companies are increasingly focusing on cloud-based solutions, which provide scalability, cost savings, and flexibility, as well as access to advanced analytics and machine learning capabilities. Vendors are also focusing on edge computing options for life science companies that need processing data close to the source.
- In May 2022, leading enterprise cloud data management company, Informatica launched the Intelligent Data Management Cloud (IDMC) for healthcare and life sciences. IDMC is the first AI-powered, cloud-neutral, data management platform in the industry with the capacity to ingest, manage, and control data in a hybrid, multi-cloud environment.
- Snowflake, a data cloud company launched the Healthcare & Life Sciences Data Cloud in March 2022 for better patient care and business results. Healthcare companies will have a unified, integrated, and cross-cloud data platform that eliminates technological and institutional data silos with the launch of Snowflake Healthcare & Life Sciences Data Cloud.
Fact.MR has provided detailed information about the service offering of key vendors of life sciences enterprise storage positioned across regions, sales growth, deployment scale, and speculative technological expansion, in the recently published report.
Segmentation of Life Sciences Enterprise Storage Research
-
By System :
- Storage-Area Network
- Network-attached storage
- Direct-Attached Storage
- Software-Defined Storage
- Hybrid
-
By Deployment :
- On-Cloud
- Public
- Private
- Hybrid
- On-Premise
- Hybrid
- On-Cloud
-
By Enterprise Size :
- Small Enterprise (Upto 50 Emp)
- Medium Enterprise (51-250 Emp)
- Large Enterprise (Above 250 Emp)
-
By End Use Industry :
- Academia & Universities
- Biotechnology Industry
- Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
- Diagnostics and Screening
- Government
- Pharmaceutical Industry
- Hospitals and Healthcare Centers
- Medical Devices Manufacturing
- Digital Health
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Market- Executive Summary 2. Market Overview 2.1. Market Definition and Introduction 2.2. Market Taxonomy/ Research Scope 3. Market Background and Foundation Data 3.1. Global Enterprise Storage System Industry Size (US$ Mn) 3.1.1. By Type 3.1.2. By Region 3.2. Penetration of in Global Enterprise Storage Market 3.3. Average Spending on by 100 End Use Industry Facilities 3.4. Block Chain & Big Data: Driving changes in the Enterprise Storage Industry 3.5. Lifesciences Industry Inclination: On-Cloud vs On-Premise 3.6. Growth and Development pattern in Lifesciences industry 3.7. Investment Feasibility Analysis 3.8. Policy and Regulatory Landscape 3.9. Market Scenario Forecast (Optimistic / Likely / Conservative) 3.10. Opportunity Assessment 3.10.1. Total Available Market (US$ Mn) 3.10.2. Serviceable Addressable Market (US$ Mn) 3.10.3. Serviceable Obtainable Market (US$ Mn) 3.11. Market Dynamics 3.11.1. Drivers 3.11.2. Restraints 3.11.3. Opportunity Analysis 3.11.4. Trends 3.12. Forecast and Macro-economic Factors – Relevance and Impact 4. Global Market Value (US$ Mn) Analysis and Forecast 4.1. Historical Market Value (US$ Mn) Analysis, 2018-2022 4.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis and Forecast, By System 5.1. Introduction / Key Findings 5.2. Historical Market Size (US$ Mn) Analysis By System, 2018-2022 5.3. Current and Future Market Size (US$ Mn) Analysis Forecast By System, 2023-2033 5.3.1. Storage-Area Network 5.3.2. Network-attached storage 5.3.3. Direct-Attached Storage 5.3.4. Software-Defined Storage 5.3.5. Hybrid 5.4. Market Attractiveness Analysis By System 6. Global Market Analysis and Forecast, By Deployment 6.1. Introduction / Key Findings 6.2. Historical Market Size (US$ Mn) Analysis By Deployment, 2018-2022 6.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Deployment, 2023-2033 6.3.1. On-Cloud 6.3.1.1. Public 6.3.1.2. Private 6.3.1.3. Hybrid 6.3.2. On-Premise 6.3.3. Hybrid 6.4. Market Attractiveness Analysis By Deployment 7. Global Market Analysis and Forecast, By Enterprise Size 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Enterprise Size, 2018-2022 7.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Enterprise Size, 2023-2033 7.3.1. Small Enterprise (Upto 50 Emp) 7.3.2. Medium Enterprise (51-250 Emp) 7.3.3. Large Enterprise (Above 250 Emp) 7.4. Market Attractiveness Analysis By Enterprise Size 8. Global Market Analysis and Forecast, By End Use Industry 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By End Use Industry, 2018-2022 8.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End Use Industry, 2023-2033 8.3.1. Academia & Universities 8.3.2. Biotechnology Industry 8.3.3. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) 8.3.4. Diagnostics and Screening 8.3.5. Government 8.3.6. Pharmaceutical Industry 8.3.7. Hospitals and Healthcare Centers 8.3.8. Medical Devices Manufacturing 8.3.9. Digital Health 8.3.10. Others 8.4. Market Attractiveness Analysis By End Use Industry 9. Global Market Analysis and Forecast, by Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022 9.3. Current Market Size (US$ Mn) Analysis Forecast By Region, 2023-2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia and Oceania 9.3.6. Middle East & Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis and Forecast 10.1. Introduction / Key Findings 10.2. Pricing Analysis 10.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 10.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 10.4.1. By Country 10.4.1.1. U.S. 10.4.1.2. Canada 10.4.2. By System 10.4.3. By Deployment 10.4.4. By Enterprise Size 10.4.5. By End Use Industry 10.5. Market Attractiveness Analysis 10.5.1. By System 10.5.2. By Deployment 10.5.3. By Enterprise Size 10.5.4. By End Use Industry 11. Latin America Market Analysis and Forecast 11.1. Introduction / Key Findings 11.2. Pricing Analysis 11.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 11.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 11.4.1. By Country 11.4.1.1. Brazil 11.4.1.2. Mexico 11.4.1.3. Argentina 11.4.1.4. Peru 11.4.1.5. Rest of Latin America 11.4.2. By System 11.4.3. By Deployment 11.4.4. By Enterprise Size 11.4.5. By End Use Industry 11.5. Market Attractiveness Analysis 11.5.1. By System 11.5.2. By Deployment 11.5.3. By Enterprise Size 11.5.4. By End Use Industry 12. Europe Market Analysis and Forecast 12.1. Introduction / Key Findings 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 12.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 12.4.1. By Country 12.4.1.1. Germany 12.4.1.2. Italy 12.4.1.3. France 12.4.1.4. U.K. 12.4.1.5. Spain 12.4.1.6. BENELUX 12.4.1.7. NORDIC 12.4.1.8. Rest of Europe 12.4.2. By System 12.4.3. By Deployment 12.4.4. By Enterprise Size 12.4.5. By End Use Industry 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By System 12.5.3. By Deployment 12.5.4. By Enterprise Size 12.5.5. By End Use Industry 13. East Asia Market Analysis and Forecast 13.1. Introduction / Key Findings 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 13.4.1. By Country 13.4.1.1. China 13.4.1.2. Japan 13.4.1.3. South Korea 13.4.2. By System 13.4.3. By Deployment 13.4.4. By Enterprise Size 13.4.5. By End Use Industry 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By System 13.5.3. By Deployment 13.5.4. By Enterprise Size 13.5.5. By End Use Industry 14. South Asia And Oceania Market Analysis and Forecast 14.1. Introduction / Key Findings 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 14.4.1. By Country 14.4.1.1. India 14.4.1.2. Thailand 14.4.1.3. Indonesia 14.4.1.4. Malaysia 14.4.1.5. Australia & New Zealand 14.4.1.6. Rest of South Asia & Oceania 14.4.2. By System 14.4.3. By Deployment 14.4.4. By Enterprise Size 14.4.5. By End Use Industry 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By System 14.5.3. By Deployment 14.5.4. By Enterprise Size 14.5.5. By End Use Industry 15. Middle East & Africa Market Analysis and Forecast 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. Turkey 15.3.1.3. Egypt 15.3.1.4. South Africa 15.3.1.5. Rest of Middle East and Africa 15.3.2. By System 15.3.3. By Deployment 15.3.4. By Enterprise Size 15.3.5. By End Use Industry 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By System 15.4.3. By Deployment 15.4.4. By Enterprise Size 15.4.5. By End Use Industry 16. Country-level Market Analysis and Forecast 16.1. Introduction / Key Findings 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.2.2.1. By System 16.2.2.2. By Deployment 16.2.2.3. By Enterprise Size 16.2.2.4. By End Use Industry 16.3. Canada Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.3.2.1. By System 16.3.2.2. By Deployment 16.3.2.3. By Enterprise Size 16.3.2.4. By End Use Industry 16.4. Brazil Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.4.2.1. By System 16.4.2.2. By Deployment 16.4.2.3. By Enterprise Size 16.4.2.4. By End Use Industry 16.5. Mexico Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.5.2.1. By System 16.5.2.2. By Deployment 16.5.2.3. By Enterprise Size 16.5.2.4. By End Use Industry 16.6. Argentina Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.6.2.1. By System 16.6.2.2. By Deployment 16.6.2.3. By Enterprise Size 16.6.2.4. By End Use Industry 16.7. Germany Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.7.2.1. By System 16.7.2.2. By Deployment 16.7.2.3. By Enterprise Size 16.7.2.4. By End Use Industry 16.8. France Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.8.2.1. By System 16.8.2.2. By Deployment 16.8.2.3. By Enterprise Size 16.8.2.4. By End Use Industry 16.9. Italy Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.9.2.1. By System 16.9.2.2. By Deployment 16.9.2.3. By Enterprise Size 16.9.2.4. By End Use Industry 16.10. Spain Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.10.3. By System 16.10.4. By Deployment 16.10.5. By Enterprise Size 16.10.6. By End Use Industry 16.11. Peru Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.11.2.1. By System 16.11.2.2. By Deployment 16.11.2.3. By Enterprise Size 16.11.2.4. By End Use Industry 16.12. NORDIC Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.12.3. By System 16.12.4. By Deployment 16.12.5. By Enterprise Size 16.12.6. By End Use Industry 16.13. BENELUX Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.13.2.1. By System 16.13.2.2. By Deployment 16.13.2.3. By Enterprise Size 16.13.2.4. By End Use Industry 16.14. U.K. Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.14.2.1. By System 16.14.2.2. By Deployment 16.14.2.3. By Enterprise Size 16.14.2.4. By End Use Industry 16.15. China Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.15.2.1. By System 16.15.2.2. By Deployment 16.15.2.3. By Enterprise Size 16.15.2.4. By End Use Industry 16.16. Japan Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.16.2.1. By System 16.16.2.2. By Deployment 16.16.2.3. By Enterprise Size 16.16.2.4. By End Use Industry 16.17. South Korea Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.17.2.1. By System 16.17.2.2. By Deployment 16.17.2.3. By Enterprise Size 16.17.2.4. By End Use Industry 16.18. India Market Analysis 16.18.1. Value Proportion Analysis by Market Taxonomy 16.18.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.18.2.1. By System 16.18.2.2. By Deployment 16.18.2.3. By Enterprise Size 16.18.2.4. By End Use Industry 16.19. ASEAN Countries Market Analysis 16.19.1. Value Proportion Analysis by Market Taxonomy 16.19.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.19.2.1. By System 16.19.2.2. By Deployment 16.19.2.3. By Enterprise Size 16.19.2.4. By End Use Industry 16.20. GCC Countries Market Analysis 16.20.1. Value Proportion Analysis by Market Taxonomy 16.20.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.20.2.1. By System 16.20.2.2. By Deployment 16.20.2.3. By Enterprise Size 16.20.2.4. By End Use Industry 16.21. Turkey Market Analysis 16.21.1. Value Proportion Analysis by Market Taxonomy 16.21.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.21.2.1. By System 16.21.2.2. By Deployment 16.21.2.3. By Enterprise Size 16.21.2.4. By End Use Industry 16.22. South Africa Market Analysis 16.22.1. Value Proportion Analysis by Market Taxonomy 16.22.2. Value (US$ Mn) Analysis and Forecast by Market Taxonomy, 2018-2033 16.22.2.1. By System 16.22.2.2. By Deployment 16.22.2.3. By Enterprise Size 16.22.2.4. By End Use Industry 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration of Players 17.3. Market Share Analysis of Top Players 17.4. Market Space for New Brands and Dollar Opportunity 17.5. Market Presence Analysis 17.5.1. By Regional Footprint of Players 17.5.2. Product Footprint by Players 18. Market Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive: Market 18.3.1. Amazon Web Services 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Key Financials 18.3.1.4. SWOT Analysis 18.3.1.5. Key Developments 18.3.1.6. Strategy Overview 18.3.2. BigMIND Home 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Key Financials 18.3.2.4. SWOT Analysis 18.3.2.5. Key Developments 18.3.2.6. Strategy Overview 18.3.3. Cloudian 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Key Financials 18.3.3.4. SWOT Analysis 18.3.3.5. Key Developments 18.3.3.6. Strategy Overview 18.3.4. DDN 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Key Financials 18.3.4.4. SWOT Analysis 18.3.4.5. Key Developments 18.3.4.6. Strategy Overview 18.3.5. Dell Inc. 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Key Financials 18.3.5.4. SWOT Analysis 18.3.5.5. Key Developments 18.3.5.6. Strategy Overview 18.3.6. Fujitsu 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Key Financials 18.3.6.4. SWOT Analysis 18.3.6.5. Key Developments 18.3.6.6. Strategy Overview 18.3.7. Hitachi 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Key Financials 18.3.7.4. SWOT Analysis 18.3.7.5. Key Developments 18.3.7.6. Strategy Overview 18.3.8. HPE 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Key Financials 18.3.8.4. SWOT Analysis 18.3.8.5. Key Developments 18.3.8.6. Strategy Overview 18.3.9. Huawei 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Key Financials 18.3.9.4. SWOT Analysis 18.3.9.5. Key Developments 18.3.9.6. Strategy Overview 18.3.10. IBM 18.3.10.1. Overview 18.3.10.2. Product Portfolio 18.3.10.3. Key Financials 18.3.10.4. SWOT Analysis 18.3.10.5. Key Developments 18.3.10.6. Strategy Overview 18.3.11. Microsoft Azure 18.3.11.1. Overview 18.3.11.2. Product Portfolio 18.3.11.3. Key Financials 18.3.11.4. SWOT Analysis 18.3.11.5. Key Developments 18.3.11.6. Strategy Overview 18.3.12. NetApp 18.3.12.1. Overview 18.3.12.2. Product Portfolio 18.3.12.3. Key Financials 18.3.12.4. SWOT Analysis 18.3.12.5. Key Developments 18.3.12.6. Strategy Overview 18.3.13. Nutanix 18.3.13.1. Overview 18.3.13.2. Product Portfolio 18.3.13.3. Key Financials 18.3.13.4. SWOT Analysis 18.3.13.5. Key Developments 18.3.13.6. Strategy Overview 18.3.14. Oracle 18.3.14.1. Overview 18.3.14.2. Product Portfolio 18.3.14.3. Key Financials 18.3.14.4. SWOT Analysis 18.3.14.5. Key Developments 18.3.14.6. Strategy Overview 18.3.15. Pure Storage 18.3.15.1. Overview 18.3.15.2. Product Portfolio 18.3.15.3. Key Financials 18.3.15.4. SWOT Analysis 18.3.15.5. Key Developments 18.3.15.6. Strategy Overview 18.3.16. Qumulo 18.3.16.1. Overview 18.3.16.2. Product Portfolio 18.3.16.3. Key Financials 18.3.16.4. SWOT Analysis 18.3.16.5. Key Developments 18.3.16.6. Strategy Overview 18.3.17. Rackspace 18.3.17.1. Overview 18.3.17.2. Product Portfolio 18.3.17.3. Key Financials 18.3.17.4. SWOT Analysis 18.3.17.5. Key Developments 18.3.17.6. Strategy Overview 18.3.18. Red Hat 18.3.18.1. Overview 18.3.18.2. Product Portfolio 18.3.18.3. Key Financials 18.3.18.4. SWOT Analysis 18.3.18.5. Key Developments 18.3.18.6. Strategy Overview 18.3.19. Scality 18.3.19.1. Overview 18.3.19.2. Product Portfolio 18.3.19.3. Key Financials 18.3.19.4. SWOT Analysis 18.3.19.5. Key Developments 18.3.19.6. Strategy Overview 18.3.20. StorCentric, Inc 18.3.20.1. Overview 18.3.20.2. Product Portfolio 18.3.20.3. Key Financials 18.3.20.4. SWOT Analysis 18.3.20.5. Key Developments 18.3.20.6. Strategy Overview 18.3.21. SUSE 18.3.21.1. Overview 18.3.21.2. Product Portfolio 18.3.21.3. Key Financials 18.3.21.4. SWOT Analysis 18.3.21.5. Key Developments 18.3.21.6. Strategy Overview 18.3.22. Violin Systems 18.3.22.1. Overview 18.3.22.2. Product Portfolio 18.3.22.3. Key Financials 18.3.22.4. SWOT Analysis 18.3.22.5. Key Developments 18.3.22.6. Strategy Overview 18.3.23. Western Digital 18.3.23.1. Overview 18.3.23.2. Product Portfolio 18.3.23.3. Key Financials 18.3.23.4. SWOT Analysis 18.3.23.5. Key Developments 18.3.23.6. Strategy Overview 18.3.24. Zoolz 18.3.24.1. Overview 18.3.24.2. Product Portfolio 18.3.24.3. Key Financials 18.3.24.4. SWOT Analysis 18.3.24.5. Key Developments 18.3.24.6. Strategy Overview 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01. Global Value (US$ million) and Historic by Region, 2018-2022
Table 02. Global Value (US$ million) and Forecast by Region, 2023-2033
Table 03. Global Value (US$ million) and Historic By Component, 2018-2022
Table 04. Global Value (US$ million) and Forecast By Component, 2023-2033
Table 05. Global Value (US$ million) and Historic By License Structure , 2018-2022
Table 06. Global Value (US$ million) and Forecast By License Structure , 2023-2033
Table 07. Global Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 08. Global Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 09. Global Value (US$ million) and Historic By Deployment , 2018-2022
Table 10. Global Value (US$ million) and Forecast By Deployment , 2023-2033
Table 11. North America Value (US$ million) and Historic by Country, 2018-2022
Table 12. North America Value (US$ million) and Forecast by Country, 2023-2033
Table 13. North America Value (US$ million) and Historic By Component, 2018-2022
Table 14. North America Value (US$ million) and Forecast By Component, 2023-2033
Table 15. North America Value (US$ million) and Historic By License Structure , 2018-2022
Table 16. North America Value (US$ million) and Forecast By License Structure , 2023-2033
Table 17. North America Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 18. North America Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 19. North America Value (US$ million) and Historic By Deployment , 2018-2022
Table 20. North America Value (US$ million) and Forecast By Deployment , 2023-2033
Table 21. Latin America Value (US$ million) and Historic by Country, 2018-2022
Table 22. Latin America Value (US$ million) and Forecast by Country, 2023-2033
Table 23. Latin America Value (US$ million) and Historic By Component, 2018-2022
Table 24. Latin America Value (US$ million) and Forecast By Component, 2023-2033
Table 25. Latin America Value (US$ million) and Historic By License Structure , 2018-2022
Table 26. Latin America Value (US$ million) and Forecast By License Structure , 2023-2033
Table 27. Latin America Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 28. Latin America Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 29. Latin America Value (US$ million) and Forecast By Deployment , 2018-2022
Table 30. Latin America Value (US$ million) and Forecast By Deployment , 2023-2033
Table 31. Europe Value (US$ million) and Historic by Country, 2018-2022
Table 32. Europe Value (US$ million) and Forecast by Country, 2023-2033
Table 33. Europe Value (US$ million) and Historic By Component, 2018-2022
Table 34. Europe Value (US$ million) and Forecast By Component, 2023-2033
Table 35. Europe Value (US$ million) and Historic By License Structure , 2018-2022
Table 36. Europe Value (US$ million) and Forecast By License Structure , 2023-2033
Table 37. Europe Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 38. Europe Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 39. Europe Value (US$ million) and Historic By Deployment , 2018-2022
Table 40. Europe Value (US$ million) and Forecast By Deployment , 2023-2033
Table 41. East Asia Value (US$ million) and Historic by Country, 2018-2022
Table 42. East Asia Value (US$ million) and Forecast by Country, 2023-2033
Table 43. East Asia Value (US$ million) and Historic By Component, 2018-2022
Table 44. East Asia Value (US$ million) and Forecast By Component, 2023-2033
Table 45. East Asia Value (US$ million) and Historic By License Structure , 2018-2022
Table 46. East Asia Value (US$ million) and Forecast By License Structure , 2023-2033
Table 47. East Asia Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 48. East Asia Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 49. East Asia Value (US$ million) and Historic By Deployment , 2018-2022
Table 50. East Asia Value (US$ million) and Forecast By Deployment , 2023-2033
Table 51. South Asia & Oceania Value (US$ million) and Historic by Country, 2018-2022
Table 52. South Asia & Oceania Value (US$ million) and Forecast by Country, 2023-2033
Table 53. South Asia & Oceania Value (US$ million) and Historic By Component, 2018-2022
Table 54. South Asia & Oceania Value (US$ million) and Forecast By Component, 2023-2033
Table 55. South Asia & Oceania Value (US$ million) and Historic By License Structure , 2018-2022
Table 56. South Asia & Oceania Value (US$ million) and Forecast By License Structure , 2023-2033
Table 57. South Asia & Oceania Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 58. South Asia & Oceania Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 59. South Asia & Oceania Value (US$ million) and Historic By Deployment , 2018-2022
Table 60. South Asia & Oceania Value (US$ million) and Forecast By Deployment , 2023-2033
Table 61. MEA Value (US$ million) and Historic by Country, 2018-2022
Table 62. MEA Value (US$ million) and Forecast by Country, 2023-2033
Table 63. MEA Value (US$ million) and Historic By Component, 2018-2022
Table 64. MEA Value (US$ million) and Forecast By Component, 2023-2033
Table 65. MEA Value (US$ million) and Historic By License Structure , 2018-2022
Table 66. MEA Value (US$ million) and Forecast By License Structure , 2023-2033
Table 67. MEA Value (US$ million) and Historic By End Use Industry, 2018-2022
Table 68. MEA Value (US$ million) and Forecast By End Use Industry, 2023-2033
Table 69. MEA Value (US$ million) and Historic By Deployment , 2018-2022
Table 70. MEA Value (US$ million) and Forecast By Deployment , 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01. Global Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 02. Global Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 03. Global Life Sciences Enterprises Value (US$ million) by Region, 2022 & 2032
Figure 04. Global Life Sciences Enterprises Y-o-Y Growth Rate by Region, 2023-2033
Figure 05. Global Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 06. Global Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 07. Global Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 08. Global Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 09. Global Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 10. Global Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 11. Global Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 12. Global Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 13. North America Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 14. North America Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 15. North America Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 16. North America Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 17. North America Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 18. North America Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 19. North America Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 20. North America Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 21. North America Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 22. North America Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 23. North America Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 24. North America Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 25. North America Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 26. North America Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 27. North America Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 28. North America Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 29. North America Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 30. Latin America Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 31. Latin America Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 32. Latin America Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 33. Latin America Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 34. Latin America Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 35. Latin America Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 36. Latin America Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 37. Latin America Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 38. Latin America Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 39. Latin America Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 40. Latin America Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 41. Latin America Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 42. Latin America Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 43. Latin America Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 44. Latin America Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 45. Latin America Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 46. Latin America Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 47. Europe Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 48. Europe Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 49. Europe Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 50. Europe Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 51. Europe Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 52. Europe Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 53. Europe Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 54. Europe Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 55. Europe Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 56. Europe Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 57. Europe Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 58. Europe Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 59. Europe Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 60. Europe Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 61. Europe Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 62. Europe Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 63. Europe Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 64. East Asia Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 65. East Asia Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 66. East Asia Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 67. East Asia Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 68. East Asia Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 69. East Asia Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 70. East Asia Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 71. East Asia Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 72. East Asia Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 73. East Asia Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 74. East Asia Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 75. East Asia Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 76. East Asia Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 77. East Asia Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 78. East Asia Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 79. East Asia Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 80. East Asia Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 81. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 82. South Asia & Oceania Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 83. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 84. South Asia & Oceania Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 85. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 86. South Asia & Oceania Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 87. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 88. South Asia & Oceania Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 89. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 90. South Asia & Oceania Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 91. South Asia & Oceania Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 92. South Asia & Oceania Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 93. South Asia & Oceania Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 94. South Asia & Oceania Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 95. South Asia & Oceania Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 96. South Asia & Oceania Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 97. South Asia & Oceania Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 98. MEA Life Sciences Enterprises Value (US$ million) and Forecast, 2023-2033
Figure 99. MEA Life Sciences Enterprises Absolute $ Opportunity (US$ million), 2023-2033
Figure 100. MEA Life Sciences Enterprises Value (US$ million) and by Country, 2022 & 2032
Figure 101. MEA Life Sciences Enterprises Y-o-Y Growth Rate by Country, 2023-2033
Figure 102. MEA Life Sciences Enterprises Value (US$ million) and By System, 2022 & 2032
Figure 103. MEA Life Sciences Enterprises Y-o-Y Growth Rate By System, 2023-2033
Figure 104. MEA Life Sciences Enterprises Value (US$ million) and By Deployment , 2022 & 2032
Figure 105. MEA Life Sciences Enterprises Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 106. MEA Life Sciences Enterprises Value (US$ million) and By Enterprise Size, 2022 & 2032
Figure 107. MEA Life Sciences Enterprises Y-o-Y Growth Rate By Enterprise Size, 2023-2033
Figure 108. MEA Life Sciences Enterprises Value (US$ million) and By End Use Industry , 2022 & 2032
Figure 109. MEA Life Sciences Enterprises Y-o-Y Growth Rate By End Use Industry , 2023-2033
Figure 110. MEA Life Sciences Enterprises Attractiveness Analysis by Country, 2023-2033
Figure 111. MEA Life Sciences Enterprises Attractiveness Analysis By System, 2023-2033
Figure 112. MEA Life Sciences Enterprises Attractiveness Analysis By Deployment , 2023-2033
Figure 113. MEA Life Sciences Enterprises Attractiveness Analysis By Enterprise Size, 2023-2033
Figure 114. MEA Life Sciences Enterprises Attractiveness Analysis By End Use Industry , 2023-2033
Figure 115. Global Value (US$ million) and Forecast, 2023-2033
Figure 116. Global Absolute $ Opportunity (US$ million), 2023-2033
Figure 117. Global Value (US$ million) by Region, 2022 & 2032
Figure 118. Global Y-o-Y Growth Rate by Region, 2023-2033
Figure 119. Global Value (US$ million) and By Component, 2022 & 2032
Figure 120. Global Y-o-Y Growth Rate By Component, 2023-2033
Figure 121. Global Value (US$ million) and By License Structure , 2022 & 2032
Figure 122. Global Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 123. Global Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 124. Global Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 125. Global Value (US$ million) and By Deployment , 2022 & 2032
Figure 126. Global Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 127. North America Value (US$ million) and Forecast, 2023-2033
Figure 128. North America Absolute $ Opportunity (US$ million), 2023-2033
Figure 129. North America Value (US$ million) and by Country, 2022 & 2032
Figure 130. North America Y-o-Y Growth Rate by Country, 2023-2033
Figure 131. North America Value (US$ million) and By Component, 2022 & 2032
Figure 132. North America Y-o-Y Growth Rate By Component, 2023-2033
Figure 133. North America Value (US$ million) and By License Structure , 2022 & 2032
Figure 134. North America Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 135. North America Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 136. North America Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 137. North America Value (US$ million) and By Deployment , 2022 & 2032
Figure 138. North America Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 139. North America Attractiveness Analysis by Country, 2023-2033
Figure 140. North America Attractiveness Analysis By Component, 2023-2033
Figure 141. North America Attractiveness Analysis By License Structure , 2023-2033
Figure 142. North America Attractiveness Analysis By End Use Industry, 2023-2033
Figure 143. North America Attractiveness Analysis By Deployment , 2023-2033
Figure 144. Latin America Value (US$ million) and Forecast, 2023-2033
Figure 145. Latin America Absolute $ Opportunity (US$ million), 2023-2033
Figure 146. Latin America Value (US$ million) and by Country, 2022 & 2032
Figure 147. Latin America Y-o-Y Growth Rate by Country, 2023-2033
Figure 148. Latin America Value (US$ million) and By Component, 2022 & 2032
Figure 149. Latin America Y-o-Y Growth Rate By Component, 2023-2033
Figure 150. Latin America Value (US$ million) and By License Structure , 2022 & 2032
Figure 151. Latin America Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 152. Latin America Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 153. Latin America Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 154. Latin America Value (US$ million) and By Deployment , 2022 & 2032
Figure 155. Latin America Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 156. Latin America Attractiveness Analysis by Country, 2023-2033
Figure 157. Latin America Attractiveness Analysis By Component, 2023-2033
Figure 158. Latin America Attractiveness Analysis By License Structure , 2023-2033
Figure 159. Latin America Attractiveness Analysis By End Use Industry, 2023-2033
Figure 160. Latin America Attractiveness Analysis By Deployment , 2023-2033
Figure 161. Europe Value (US$ million) and Forecast, 2023-2033
Figure 162. Europe Absolute $ Opportunity (US$ million), 2023-2033
Figure 163. Europe Value (US$ million) and by Country, 2022 & 2032
Figure 164. Europe Y-o-Y Growth Rate by Country, 2023-2033
Figure 165. Europe Value (US$ million) and By Component, 2022 & 2032
Figure 166. Europe Y-o-Y Growth Rate By Component, 2023-2033
Figure 167. Europe Value (US$ million) and By License Structure , 2022 & 2032
Figure 168. Europe Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 169. Europe Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 170. Europe Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 171. Europe Value (US$ million) and By Deployment , 2022 & 2032
Figure 172. Europe Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 173. Europe Attractiveness Analysis by Country, 2023-2033
Figure 174. Europe Attractiveness Analysis By Component, 2023-2033
Figure 175. Europe Attractiveness Analysis By License Structure , 2023-2033
Figure 176. Europe Attractiveness Analysis By End Use Industry, 2023-2033
Figure 177. Europe Attractiveness Analysis By Deployment , 2023-2033
Figure 178. East Asia Value (US$ million) and Forecast, 2023-2033
Figure 179. East Asia Absolute $ Opportunity (US$ million), 2023-2033
Figure 180. East Asia Value (US$ million) and by Country, 2022 & 2032
Figure 181. East Asia Y-o-Y Growth Rate by Country, 2023-2033
Figure 182. East Asia Value (US$ million) and By Component, 2022 & 2032
Figure 183. East Asia Y-o-Y Growth Rate By Component, 2023-2033
Figure 184. East Asia Value (US$ million) and By License Structure , 2022 & 2032
Figure 185. East Asia Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 186. East Asia Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 187. East Asia Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 188. East Asia Value (US$ million) and By Deployment , 2022 & 2032
Figure 189. East Asia Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 190. East Asia Attractiveness Analysis by Country, 2023-2033
Figure 191. East Asia Attractiveness Analysis By Component, 2023-2033
Figure 192. East Asia Attractiveness Analysis By License Structure , 2023-2033
Figure 193. East Asia Attractiveness Analysis By End Use Industry, 2023-2033
Figure 194. East Asia Attractiveness Analysis By Deployment , 2023-2033
Figure 195. South Asia & Oceania Value (US$ million) and Forecast, 2023-2033
Figure 196. South Asia & Oceania Absolute $ Opportunity (US$ million), 2023-2033
Figure 197. South Asia & Oceania Value (US$ million) and by Country, 2022 & 2032
Figure 198. South Asia & Oceania Y-o-Y Growth Rate by Country, 2023-2033
Figure 199. South Asia & Oceania Value (US$ million) and By Component, 2022 & 2032
Figure 200. South Asia & Oceania Y-o-Y Growth Rate By Component, 2023-2033
Figure 201. South Asia & Oceania Value (US$ million) and By License Structure , 2022 & 2032
Figure 202. South Asia & Oceania Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 203. South Asia & Oceania Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 204. South Asia & Oceania Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 205. South Asia & Oceania Value (US$ million) and By Deployment , 2022 & 2032
Figure 206. South Asia & Oceania Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 207. South Asia & Oceania Attractiveness Analysis by Country, 2023-2033
Figure 208. South Asia & Oceania Attractiveness Analysis By Component, 2023-2033
Figure 209. South Asia & Oceania Attractiveness Analysis By License Structure , 2023-2033
Figure 210. South Asia & Oceania Attractiveness Analysis By End Use Industry, 2023-2033
Figure 211. South Asia & Oceania Attractiveness Analysis By Deployment , 2023-2033
Figure 212. MEA Value (US$ million) and Forecast, 2023-2033
Figure 213. MEA Absolute $ Opportunity (US$ million), 2023-2033
Figure 214. MEA Value (US$ million) and by Country, 2022 & 2032
Figure 215. MEA Y-o-Y Growth Rate by Country, 2023-2033
Figure 216. MEA Value (US$ million) and By Component, 2022 & 2032
Figure 217. MEA Y-o-Y Growth Rate By Component, 2023-2033
Figure 218. MEA Value (US$ million) and By License Structure , 2022 & 2032
Figure 219. MEA Y-o-Y Growth Rate By License Structure , 2023-2033
Figure 220. MEA Value (US$ million) and By End Use Industry, 2022 & 2032
Figure 221. MEA Y-o-Y Growth Rate By End Use Industry, 2023-2033
Figure 222. MEA Value (US$ million) and By Deployment , 2022 & 2032
Figure 223. MEA Y-o-Y Growth Rate By Deployment , 2023-2033
Figure 224. MEA Attractiveness Analysis by Country, 2023-2033
Figure 225. MEA Attractiveness Analysis By Component, 2023-2033
Figure 226. MEA Attractiveness Analysis By License Structure , 2023-2033
Figure 227. MEA Attractiveness Analysis By End Use Industry, 2023-2033
Figure 228. MEA Attractiveness Analysis By Deployment , 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What will be the valuation of life sciences enterprise storage market in 2033?
The market is likely to reach a valuation of US$ 4.5 Billion by the end of forecast period.
What will be the valuation of on-premise deployment of life sciences enterprise storage in 2023?
The on-premise deployment of life sciences enterprise storage is likely to reach a valuation of around US$ 635.9 Mn in 2023.
Which region dominates the value generation in overall market?
North America holds the leading market share by around 34.3% in 2023 and is presumed to remain in same growth curve by the end of 2033.
Which end use industry will have the highest market share in 2023?
Pharmaceutical industry will have the highest market share by 19.3% in 2023.
What is the market value of Europe region in 2023?
Europe region is likely to offer great growth prospect with a market valuation of US$ 689.5 Mn in 2023.
How much market share will China capture in 2023 of global market?
China is expected to hold a market share of around 10.5% in 2023 at global level and is expected to grow in same rate by a CAGR of 4.7%.
What will be the market valuation of storage-area network under system segment in 2023?
Storage-area network under system segment is expected to reach a market valuation of US$ 754.9 Mn by 2023.
Life Sciences Enterprise Storage Market